Summit Therapeutics
SMMT
$3.92
Share price
1.42%
Change (1 day)
196.59%
Change (1 year)
Categories
Operating Margin for Summit Therapeutics (SMMT)
Operating Margin as of April 2024 (TTM): -11,174.80%
According to Summit Therapeutics 's latest financial reports and stock price the company's current Operating Margin is -11,174.80%. At the end of 2022 the company had an Operating Margin of -11,174.75%.
Operating Margin history for Summit Therapeutics from 2016 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -11,174.75% | 128.16% |
| 2021 | -4,897.84% | -20.39% |
| 2020 | -6,152.33% | -52698.65% |
| 2019 | 11.70% | -127.29% |
| 2018 | -42.85% | -96.16% |
| 2017 | -1,115.76% | |
| 2014 | -487.27% | 93.59% |
| 2013 | -251.71% | 48.19% |
| 2012 | -169.86% | -78.09% |
| 2011 | -775.36% | -74.82% |
| 2010 | -3,078.84% | -56.52% |
| 2009 | -7,081.08% | 1844.68% |
| 2008 | -364.13% | 7.3% |
| 2007 | -339.36% | 48.12% |
| 2006 | -229.11% | 269.86% |
| 2005 | -61.95% | -97.31% |
| 2004 | -2,300.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Sarepta Therapeutics
SRPT | -88.19% | -99.21% | 🇺🇸 USA |
 Merrimack Pharmaceuticals MACK | -106.40% | -99.05% | 🇺🇸 USA |
 Coherus BioSciences
CHRS | -129.89% | -98.84% | 🇺🇸 USA |
 Arena Pharmaceuticals
ARNA | N/A | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.